| Pharmaceutical Information |
| Drug Name |
Tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate |
| Drug ID |
BADD_D02188 |
| Description |
Tetrakis (2-methoxyisobutylisocyanide) copper (I) tetrafluoroborate is a component of Cardiolite, a technetium Tc99m-based imaging agent used for assessing myocardial perfusion.[L12744] |
| Indications and Usage |
Not Available |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB14106
|
| KEGG ID |
Not Available
|
| MeSH ID |
Not Available
|
| PubChem ID |
92043160
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
58272-200; 65044-0020; 11994-003; 11994-001; 50384-2804 |
| UNII |
N6OU7HJ70P
|
| Synonyms |
Not Available |
|
| Chemical Information |
| Molecular Formula |
C24H44BCuF4N4O4 |
| CAS Registry Number |
103694-84-4 |
| SMILES |
[B-](F)(F)(F)F.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)
(C[N+]#[C-])OC.[Cu+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
